Browse by Journal Title

2020

In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe(2) and NHC*-Au-S-GLUC against advanced prostate cancer PC3.
Walther, W., Althagafi, D., Curran, D., O'Beirne, C., Mc Carthy, C., Ott, I., Basu, U., Büttner, B., Sterner-Kock, A., Müller-Bunz, H., Sánchez-Sanz, G., Zhu, X. and Tacke, M.
Anti-Cancer Drugs 31 (7): 672-683. August 2020

2012

Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma.
Floercken, A., Takvorian, A., Van Lessen, A., Singh, A., Hopfenmueller, W., Doerken, B., Pezzutto, A. and Westermann, J.
Anti-Cancer Drugs 23 (3): 298-302. March 2012

2008

HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.
Wegener, D., Deubzer, H.E., Oehme, I., Milde, T., Hildmann, C., Schwienhorst, A. and Witt, O.
Anti-Cancer Drugs 19 (9): 849-857. October 2008

2006

Anti-tumor activity of Titanocene Y in xenografted Caki-1 tumors in mice.
Fichtner, I., Pampillon, C., Sweeney, N.J., Strohfeldt, K. and Tacke, M.
Anti-Cancer Drugs 17 (3): 333-336. March 2006

2004

Reduction of tamoxifen resistance in human breast carcinomas by tamoxifen-containing liposomes in vivo.
Zeisig, R., Rueckerl, D. and Fichtner, I.
Anti-Cancer Drugs 15 (7): 707-714. 1 August 2004

2003

Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study.
Thuss-Patience, P.C., von Minckwitz, G., Kretzschmar, A., Loibl, S., Schaller, G., Doerken, B. and Reichardt, P.
Anti-Cancer Drugs 14 (7): 549-553. 1 August 2003

1997

Effects of amifostine (WR-2721, ethyol) on tumor growth and pharmacology of cytotoxic drugs in human xenotransplanted neuroblastomas.
Fichtner, I., Lemm, M., Becker, M. and Berthold, F.
Anti-Cancer Drugs 8 : 174-181. 1 January 1997

1993

Antineoplastic activity in vitro of free and liposomal alkylphosphocholines.
Zeisig, R., Jungmann, S., Arndt, D., Schuett, A. and Nissen, E.
Anti-Cancer Drugs 4 : 57-64. 1 January 1993

1991

Pharmacokinetic behavior of 57CO-Bleomycin liposomes in mice: comparison with the unencapsulated substance.
Fichtner, I., Arndt, D., Reszka, R. and Gens, J.
Anti-Cancer Drugs 2 : 555-563. 1 January 1991

Antitumor effects of alkylphosphocholines in different murine tumor models, use of liposomal preparations.
Zeisig, R., Fichtner, I., Arndt, D. and Jungmann, S.
Anti-Cancer Drugs 2 : 411-417. 1 January 1991